Nanjing Qingpu Biotechnology Co., Ltd.
清普生物科技
Nanjing Qingpu Biotechnology Co., Ltd.
Biotech/Healthcare
Qingpu Biotechnology is an emerging, clinical-needs-driven company focused on developing improved new drugs for dual regulatory filings in China and the United States. It has built a broad product pipeline based on its proprietary XisGel® technology platform.
Latest round: Series C (2026)
Source: ChinaBulls — chinabulls.com
Last updated 2026-07-22
Funding history
Request access to view this section.
Investors
Request access to view this section.
HQ & website
Request access to view this section.
Tags
Request access to view this section.